ALBIREO PHARMA INC's ticker is ALBO and the CUSIP is 01345P106. A total of 50 filers reported holding ALBIREO PHARMA INC in Q1 2018. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $580,000 | -72.5% | 29,000 | -55.7% | 0.06% | -73.6% |
| Q2 2019 | $2,112,000 | -67.3% | 65,500 | -67.3% | 0.23% | -68.0% |
| Q1 2019 | $6,458,000 | +31.3% | 200,500 | 0.0% | 0.72% | +12.4% |
| Q4 2018 | $4,918,000 | -31.8% | 200,500 | -8.4% | 0.64% | +1.4% |
| Q3 2018 | $7,212,000 | -7.7% | 218,800 | -0.5% | 0.63% | -16.8% |
| Q2 2018 | $7,810,000 | +6.6% | 220,000 | -2.2% | 0.76% | +2.6% |
| Q1 2018 | $7,328,000 | – | 225,000 | – | 0.74% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Prosight Management, LP | 198,800 | $5,266,000 | 2.26% |
| Perceptive Advisors | 1,960,139 | $51,924,000 | 0.84% |
| Chicago Capital, LLC | 502,212 | $13,304,000 | 0.77% |
| Birchview Capital, LP | 48,000 | $1,272,000 | 0.77% |
| Artal Group S.A. | 500,360 | $13,255,000 | 0.37% |
| HEARTLAND ADVISORS INC | 150,000 | $3,974,000 | 0.35% |
| Eversept Partners, LP | 78,029 | $2,066,988 | 0.28% |
| ArrowMark Colorado Holdings LLC | 956,990 | $25,351,000 | 0.26% |
| PA Capital LLC | 12,987 | $344,000 | 0.25% |
| Ikarian Capital, LLC | 100,500 | $2,662,000 | 0.21% |